Controlling postprandial hyperglycemia

American Journal of Cardiology

Volumn 88, Issue 2 SUPPL. 2, 2001, Pages

  Ratner, Robert E ^a  

^a MEDSTAR RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; BIGUANIDE DERIVATIVE; CHLORPROPAMIDE; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; MEGLITINIDE; METFORMIN; MIGLITOL; NATEGLINIDE; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SIBUTRAMINE; SULFONYLUREA DERIVATIVE; TETRAHYDROLIPSTATIN; THIAZOLIDINE DERIVATIVE; TOLBUTAMIDE; TROGLITAZONE; VOGLIBOSE; DYE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; PLACEBO;

BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIET RESTRICTION; EXERCISE; GLUCOSE BLOOD LEVEL; GLYCOSYLATION; HUMAN; HYPERGLYCEMIA; LIVER TOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; STANDARD; SYMPTOMATOLOGY; WEIGHT REDUCTION; CARDIOVASCULAR RISK; CONFERENCE PAPER; DIABETIC DIET; DIAGNOSTIC VALUE; DISEASE COURSE; DRUG EFFECT; DRUG SAFETY; GLUCOSE METABOLISM; METABOLIC DISORDER; OBESITY; PARAMETER; SIDE EFFECT;

ALPHA-GLUCOSIDASES; BIGUANIDES; BLOOD GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; INSULIN; POSTPRANDIAL PERIOD; SULFONYLUREA COMPOUNDS;

EID: 0035954848     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9149(01)01834-3     Document Type: Review

References (42)

1. Postprandial hyperglycaemic state: Importance and consequences
2. Postprandial hyperglycaemia and α-glucosidase inhibitors
3. Standards of care for patients with diabetes mellitus
4. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes
5. Impaired glucose tolerance as a disease
6. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
7. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
8. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
9. The UK Prospective Diabetes Study (UKPDS): Clinical and therapeutic implications for type 2 diabetes
10. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes: Progressive requirement for multiple therapies (UKPDS 49)
11. Intensive insulin therapy in patients with type 2 diabetes: Implications of the Veterans Affairs (VA CSDM) feasibility trial
12. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial: Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes
13. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes requiring insulin therapy
14. Maternal postprandial glucose levels and infant birth weight: The Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development: Diabetes in Early Pregnancy Study
15. What is the optimal postprandial glucose monitoring system in gestational diabetes?
16. The pharmacological treatment of hyperglycemia in NIDDM
17. Overview of current therapeutic options in type 2 diabetes: Rationale for combining oral agents with insulin therapy
18. Mechanisms of the glycaemic effects of sulfonylureas
19. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM: Results of two multicenter, randomized, placebo-controlled clinical trials
20. Multicenter comparison of glyburide and glipizide in the treatment of non-insulin-dependent diabetes mellitus
21. Glimepiride: A review of its use in the management of type 2 diabetes mellitus
22. A placebo-controlled, randomized study of glimepiride in patients with type 2 diabetes mellitus for whom diet therapy is unsuccessful
23. Repaglinide therapy in the treatment of type 2 diabetes
24. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes
25. Repaglinide versus glyburide: A one-year comparison
26. Synergistic effects of nateglinide and meal administration on insulin secretion in patients with type 2 diabetes mellitus
27. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus
28. Efficacy of metformin in type II diabetes: Results of a double-blind, placebo-controlled, dose-response trial
29. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus
30. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
31. Rosiglitazone once or twice daily improves glycemic control in patients with type 2 diabetes
32. Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes
33. New type 2 diabetes drugs
34. Alpha-glucosidase inhibitors
35. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus after oral agent failure
36. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years
37. The impact of pharmacotherapy on weight management in type 2 diabetes
38. Role of orlistat in the treatment of obese patients with type 2 diabetes: A 1-year randomized double-blind study
39. Type 2 diabetes mellitus: The grand overview
40. Triple oral antidiabetic therapy in type 2 diabetes mellitus
41. Drug therapy of postprandial hyperglycemia
42. Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes